Information  X 
Enter a valid email address

Coca-Cola Euro Ptrns (0RH7)

  Print      Mail a friend

Friday 15 March, 2019

Coca-Cola Euro Ptrns

Transaction in Own Shares

RNS Number : 0453T
Coca-Cola European Partners plc
15 March 2019
 

15 March 2019

 

COCA-COLA EUROPEAN PARTNERS PLC

(the "Company")

 

Transactions in Own Shares

 

The Company announces that it has purchased the following number of its ordinary shares of EUR 0.01 each through Credit Suisse Securities (USA) LLC. The purchased shares have all been cancelled.

 

These share purchases form part of the Company's existing buyback programme, as announced on 12 September 2018, in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 31 May 2018 (the "Buyback Programme"). The Company will make further announcements in due course following the completion of any further purchases pursuant to the Buyback Programme.

 

USX purchases

 

Daily aggregated information by trading venue

 

Date of purchase

Aggregate number of ordinary shares of EUR 0.01 each purchased

Lowest price paid per share (USX)

Highest price paid per share (USX)

Volume weighted average price paid per share (USX)

Trading venue

08 March 2019

103,000

47.44

47.80

47.631478

New York Stock Exchange ("NYSE")

11 March 2019

764

48.88

49.02

48.934398

BATS Global Markets ("BATS")

11 March 2019

437

48.95

49

48.965675

Boston Stock Exchange ("BSE")

11 March 2019

100

49.00

49.00

49.000000

IEX ("IEXG")

11 March 2019

98

48.93

48.93

48.930000

NASDAQ ("NASDAQ")

11 March 2019

63,101

48.22

49.03

48.685426

NYSE

11 March 2019

1,300

48.93

49.01

48.962308

OTC Markets ("OTC")

11 March 2019

1,200

48.91

49.03

49.005000

CBOE EDGX Equity Exchange ("XDEX")

12 March 2019

58

48.99

48.99

48.990000

BATS Global Markets Secondary

Exchange ("BYX")

12 March 2019

121,342

48.76

49.1

48.903309

NYSE

12 March 2019

25,000

48.95

48.95

48.950000

OTC Markets ("OTC")

13 March 2019

350

48.87

48.89

48.875714

BATS

13 March 2019

200

48.86

48.87

48.865000

BSE

13 March 2019

400

48.86

48.89

48.870000

BYX

13 March 2019

1,030

48.86

48.88

48.864184

CFX Alternative Trading ("CFX")

13 March 2019

3,516

48.865

48.885

48.868413

IEXG

13 March 2019

1,000

48.86

48.88

48.869500

NASDAQ

13 March 2019

100

48.86

48.86

48.860000

NYSE - National Exchange ("NSX")

13 March 2019

108,011

48.85

48.95

48.900867

NYSE

13 March 2019

800

48.8575

48.885

48.869063

OTC

13 March 2019

100

48.88

48.88

48.880000

NYSE Arca ("PSE")

13 March 2019

100

48.86

48.86

48.860000

CBOE EDGA Equity Exchange ("XDEA")

13 March 2019

24,393

48.86

48.89

48.888909

XDEX

14 March 2019

100

48.81

48.81

48.810000

BATS

14 March 2019

100

48.82

48.82

48.820000

BSE

14 March 2019

100

48.81

48.81

48.810000

BYX

14 March 2019

200

48.81

48.82

48.815000

IEXG

14 March 2019

100

48.81

48.81

48.810000

NASDAQ

14 March 2019

78,700

48.56

48.85

48.719091

NYSE

14 March 2019

100

48.81

48.81

48.810000

PSE

14 March 2019

100

48.81

48.82

48.815900

XDEX

 

Transaction details

 

The table below contains detailed information of the individual USX trades made by Credit Suisse Securities (USA) LLC as part of the Buyback Programme.

 

Schedule of purchases

 

Shares purchased:

Coca-Cola European Partners plc, (ISIN: GB00BDCPN049)

Dates of purchases:

08, 11, 12, 13 and 14 March 2019

Investment firm:

Credit Suisse Securities (USA) LLC

 

Individual transactions

 

A full breakdown of the individual transactions can be viewed at:

https://www.ccep.com/system/file_resources/5151/190315_Weekly_Buyback_Programme_indiv_trade_details_Cover_page.pdf

 

COCA-COLA EUROPEAN PARTNERS PLC

Paul van Reesch

Deputy Company Secretary

+44 (0) 1895 231 313


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
POSFELFFKXFZBBZ

a d v e r t i s e m e n t